Effect of antihypertensive deprescribing on serious adverse events, mortality, and cardiovascular disease: Long-term follow-up of the OPTiMISE randomised controlled trial

Podobne zapisy

• Effect of antihypertensive deprescribing on hospitalisation and mortality: long-term follow-up of the OPTiMISE randomised controlled trial
  od: Sheppard, JP, i wsp.
  Wydane: (2024)
• Cost-effectiveness of antihypertensive deprescribing in primary care: a Markov modelling study using data from the OPTiMISE trial
  od: Jowett, S, i wsp.
  Wydane: (2022)
• Effect of antihypertensive deprescribing on hospitalisation and mortality: long-term follow-up of the OPTiMISE randomised controlled trial
  od: James P Sheppard, PhD, i wsp.
  Wydane: (2024-08-01)
• Blood pressure changes following antihypertensive medication reduction, by drug class and dose chosen for withdrawal: exploratory analysis of data from the OPTiMISE trial
  od: Sheppard, J, i wsp.
  Wydane: (2021)
• OPtimising treatment for mild Systolic hypertension in the elderly (OPTiMISE): protocol for a randomised controlled non-inferiority trial
  od: Sheppard, J, i wsp.
  Wydane: (2018)